Company: INV
Filing Date: 2025-03-31
Form Type: NT 10-K
Source: 0001140361-25-011419
Chunk: 4

Company: Innventure, Inc.
Filing Date: 2025-03-31
Form: NT 10-K
Chunk 4
---
 of cash, capital expenditures, and the Company’s and its subsidiaries’ ability to invest in growth initiatives; the implementation, market acceptance and success of the Company’s and its subsidiaries’ business models and growth strategies; the Company’s and its subsidiaries’ future capital requirements and sources and uses of cash; the Company’s ability to meet the various conditions, including the available cash and performance targets and issuance of warrant instruments to WTI Fund X, Inc. and WTI Fund XI, Inc. (collectively, the “WTI Lenders”), and access any additional installments draws, if available, under a term loan with the WTI Lenders providing for a term loan facility in an aggregate principal amount of up to $50 million; the Company’s ability to meet the various conditions and satisfy the various limitations under the Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, Ltd. (“YA”), including exchange caps, issuances and subscriptions based on trading volumes, to continue to access the funds available under the SEPA, or the Securities Purchase Agreement and related convertible debentures with YA due to certain conditions, restrictions and limitations set forth therein; certain restrictions and limitations set forth in the Company’s debt instruments, which may impair the Company’s financial and operating flexibility; the Company’s and its subsidiaries’ ability to generate liquidity and maintain sufficient capital to operate as anticipated; the Company’s and its subsidiaries’ ability to obtain funding for their operations and future growth and to continue as going concerns; the risk that the technology solutions that the Company and its subsidiaries license or acquire from third parties or develop internally may not function as anticipated or provide the benefits anticipated; developments and projections relating to the Company’s and its subsidiaries’ competitors and industry; the ability of the Company and its subsidiaries to scale the operations of their respective businesses; the ability of the Company and its subsidiaries to establish substantial commercial sales of their products; the ability of the Company and its subsidiaries to compete against companies with greater capital and other resources or superior technology or products; the Company and its subsidiaries’ ability to meet, and to continue to meet, applicable regulatory requirements for the use of their respective products and the numerous regulatory requirements generally applicable to their respective businesses; the outcome of any legal proceedings against the Company or its subsidiaries; the Company’s ability to find future opportunities to license or acquire breakthrough technology solutions from multinational corporations or other third parties (“Technology Solutions Providers”) and to satisfy the requirements imposed by or to avoid disagreements with its current and future Technology Solutions Providers; the risk that the launch of